Background/Aim: Local blood flow failure (no-reflow phenomenon) during ischemia/reperfusion (I/R) injury may be mediated by interstitial edema formation (passive vasoconstriction) and/or microvascular spasm (active vasoconstriction). The development of the no-reflow phenomenon in the rabbit hind limb I/R model and the influence of treatment with L-arginine and/or antioxidative vitamins were investigated. Methods: Untreated rabbits were compared with those treated with L-arginine (4 mg/kg/min) or antioxidative vitamins (0.4 ml/kg) alone or in combination during hind limb I/R (2.5/2 h). Interstitial edema formation and microvessel diameter alterations were measured morphometrically. Capillary blood perfusion was measured continuously with laser Doppler flowmetry. Results: I/R injury was expressed by interstitial edema formation (interstitial space increase by 80%), microvascular constriction (microvessel cross-sectional area decrease by 30%), and development of no-reflow phenomenon (blood flow reduction by 60%). Treatment with antioxidative vitamins alone or L-arginine alone reduced interstitial edema by 22 and 31%, consequently, while combined L-arginine/antioxidative vitamin treatment showed a more pronounced edema reduction by 40%. Treatment with only antioxidative vitamins failed to influence the development of no-reflow, although interstitial edema formation was reduced. L-Arginine treatment alone or in combination with antioxidative vitamins prevented microvascular constriction and preserved blood flow after reperfusion without development of no-reflow despite still apparent interstitial edema. Conclusions: Affections of active vasomotility and not merely passive changes of external pressure (i.e., interstitial edema formation) should be considered important in the development of microvascular constriction during ‘no-reflow’ phenomenon.

Keywords:
Ischemia/reperfusion injury, No-reflow phenomenon, Interstitial edema, L-Arginine, Antioxidative vitamins
1.
Harris AG, Leiderer R, Peer F, Messmer K: Skeletal muscle microvascular and tissue injury after varying durations of ischemia. Am J Physiol Heart Circ Physiol 1996;271:H2388–H2398.
2.
Nanobashvili J, Neumayer C, Fuegl A, Sporn E, Prager M, Polterauer P, Malinski T, Huk I: Ischemia/reperfusion injury of skeletal muscle: Mechanisms, morphology, treatment strategies, and clinical applications. Eur Surg 2002;34:83–89.
3.
Ames A, Wright RL, Kowada MK, Thurston JM, Majno G: Cerebral ischemia – the no reflow phenomenon. Am J Pathol 1968;52:437–453.
4.
Allen DM, Chen LE, Seaber AV, Urbaniak JR: Pathophysiology and related studies of the no reflow phenomenon in skeletal muscle. Clin Orthop 1995;314:122–133.
5.
Gute DC, Ishida T, Yarimizu K, Korthuis RJ: Inflammatory responses to ischemia and reperfusion in skeletal muscle. Mol Cell Biochem 1998;179:169–187.
6.
Huk I, Nanobashvili J, Neumayer C, Punz A, Müller M, Afkhampour K, Mittlboeck M, Losert U, Polterauer P, Roth E, Patton S, Malinski T: L-Arginine treatment alters the kinetics of nitric oxide and superoxide release and reduces ischaemia/reperfusion injury in skeletal muscle. Circulation 1997;96:667–675.
7.
Gryglewski RJ, Palmer RM, Moncada S: Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 1986;320:454–456.
8.
Menger MD, Rücker M, Vollmar B: Capillary dysfunction in striated muscle ischemia/reperfusion: On the mechanism of capillary ‘no-reflow’. Shock 1997;8:2–7.
9.
Oredsson S, Plate G, Qvarfordt P: Experimental evaluation of oxygen free radical scavengers in the prevention of reperfusion injury in skeletal muscle. Eur J Surg 1994;160:97–103.
10.
Welbourn CR, Goldman G, Paterson IS, Valeri CR, Shepro D, Hechtman HB: Pathophysiology of ischaemia reperfusion injury: Central role of the neutrophil. Br J Surg 1991;78:651–655.
11.
Huk I, Nanobashvili J, Punz A, Lassner H, Müller M, Siegl H, Neumayer C, Mittlboeck M, Roth E: Influence of a short-term acute ischemia and reperfusion on skeletal muscle metabolism and morphology in rabbits. Int J Angiol 1996;5:59–63.
12.
Oliver JA: Endothelium-derived relaxing factor contributes to the regulation of endothelial permeability. J Cell Physiol 1992;151:506–511.
13.
Kurose I, Wolf R, Grisham MB, Granger DN: Modulation of ischemia/reperfusion-induced microvascular dysfunction by nitric oxide. Circ Res 1994;74:376–382.
14.
Filep JG, Foldes-Filep E, Sirois P: Nitric oxide modulates vascular permeability in the rat coronary circulation. Br J Pharmacol 1993;108:323–326.
15.
Ragan DM, Schmidt EE, MacDonald IC, Groom AC: Spontaneous cyclic contractions of the capillary wall in vivo, impending red cell flow: A quantitative analysis. Evidence for endothelial contractility. Microvasc Res 1988;36:13–30.
16.
Herman IM, Newcomb PM, Coughlin JE, Jacobson S: Characterization of microvascular cell cultures from normotensive and hypertensive rat brains: Pericyte-endothelial cell interactions in vitro. Tissue Cell 1987;19:197–206.
17.
Joyce NC, Haire MF, Palade GE: Contractile proteins in pericytes. I. Immunoperoxidase localisation of tropomyosin. J Cell Biol 1985;100:1379–1386.
18.
Kelley C, D’Amore P, Hechtman HB, Shepro D: Vasoactive hormones and cAMP affect pericyte contraction and stress fibres in vitro. J Muscle Res Cell Motil 1988;9:184–194.
19.
Skalli O, Pelte MF, Peclet MC, Gabbiani G, Gugliotta P, Bussolati G, Ravazzola M, Orci L: Alpha-smooth muscle actin, a differentiation marker of smooth muscle cells, is present in microfilamentous bundles of pericytes. J Histochem Cytochem 1989;37:315–321.
20.
Chan LS, Li WY, Khatami M, Rockley JH: Actin in cultured bovine retinal capillary pericytes: Morphological and functional correlation. Exp Eye Res 1986;43:41–54.
21.
Gillies MC, Su T: High glucose inhibits retinal capillary pericyte contractility in vitro. Invest Opthalmol Vis Sci 1993;34:3396–3401.
22.
Morris JL: Catecholamines increase urine formation in isolated toad (Bufo marinus) kidneys perfused at constant rate. Comp Biochem Physiol C 1984;79:219–225.
23.
Ramachandran E, Frank RN, Kennedy A: Effects of endothelin on cultured bovine retinal microvascular pericytes. Invest Opthalmol Vis Sci 1993;34:586–595.
24.
Sims DE, Miller FN, Home MM, Edwards MJ: Interleukin-2 alters the positions of capillary and venule pericytes in rat cremaster muscle. J Submicrosc Cytol Pathol 1994;26:507–513.
25.
Sakagami K, Kawamura H, Wu DM, Puro DG: Nitric oxide/cGMP-induced inhibition of calcium and chloride currents in retinal pericytes. Microvasc Res 2001;62:196–203.
© 2003 S. Karger AG, Basel
2003
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.